Month: May 2022

Posted on | Posted on John Murphy | Leave a Comment on Patients Treated with Pfizer’s Paxlovid Experience Second Round of Covid-19 Shortly After Recovering – Doctors are Baffled

Patients Treated with Pfizer’s Paxlovid Experience Second Round of Covid-19 Shortly After Recovering – Doctors are Baffled

Authors:  Benjamin Ryan Published April 29, 2022 NBC Health Pfizer’s antiviral pills are highly effective at keeping people with Covid out of the hospital, but there are growing reports that,…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on COVID “long-haulers” may have finally found relief in inexpensive, over-the-counter drugs

COVID “long-haulers” may have finally found relief in inexpensive, over-the-counter drugs

Small studies suggest over-the-counter antihistamines can relieve long COVID symptoms Authors:  NICOLE KARLIS May 21, 2022 21, 2022 Two women have recovered from post-acute sequelae of SARS-CoV-2 infection (PASC), a condition more…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient

Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient

Authors: Jérôme Dumortiera,b,⁎ Clin Res Hepatol Gastroenterol. 2022 Jan; 46(1):101743.16.  doi: 10.1016/j.clinre.2021.101743 PMCID: PMC8214934PMID: 34146727 Coronavirus disease-2019 (Covid-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is an ongoing global pandemic of major concern,…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Nonintegrating Direct Conversion Using mRNA into Hepatocyte-Like Cells

Nonintegrating Direct Conversion Using mRNA into Hepatocyte-Like Cells

Authors:: angtae Yoon, 1 , 2 Kyojin Kang, 1 , 2 Young-duck Cho, 3 Yohan Kim, 1 , 2 Elina Maria Buisson, 1 , 2 Ji-Hye Yim, 1 , 2 Seung Bum Lee, 4 Ki-Young Ryu, 5 Jaemin Jeong, 1 , 2 and Dongho Choi 1 , 2 Biomed Res Int. 2018; 2018: 8240567.Published online 2018 Sep…[...]

Read More